Use of angiotensin receptor blockers in cardiovascular protection. Current evidence and future directions

Use of angiotensin receptor blockers in cardiovascular protection. Current evidence and future directions

Aim. To differentiate angiotensin II receptor blockers (ARBs) by vascular effects and outcomes in trials on cardioprotective endpoints. Data sources. MEDLINE searches were conducted from January 2003 to March 2009 using the following search terms: renin-angiotensin-aldosterone system (RAAS) blockade...

Full description

Saved in:
Bibliographic Details
Main Author: M. A. Munger
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 1970-01-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
atrial fibrillation
candesartan
cardiovascular disease
cardioprotection
end-organ protection
eprosartan
heart failure
hypertension
high blood pressure
irbesartan
losartan
olmesartan
renin-angiotensinaldosterone system (raas)
telmisartan
valsartan
vascular protection
Online Access:https://cardiovascular.elpub.ru/jour/article/view/2003
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://cardiovascular.elpub.ru/jour/article/view/2003

Similar Items